SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-17-013407
Filing Date
2017-12-19
Accepted
2017-12-19 14:23:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g1217farwell_viking.htm SC 13G 48384
  Complete submission text file 0001213900-17-013407.txt   49615
Mailing Address 1240 ARBOR RD. MENLO PARK CA 94025
Business Address
Farwell Grosvenor Nicholas (Filed by) CIK: 0001315754 (see all company filings)

Type: SC 13G

Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Subject) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88828 | Film No.: 171263666
SIC: 2834 Pharmaceutical Preparations